Find your path to Bob
475 people in our graph share verified history with Bob — schools, employers, funds. One of them is your warm intro.
Michael TaylorunlockedBob: together at Wyeth Pharmaceuticals (2006–2007)
×3Bob: together at Wyeth Pharmaceuticals
×8Bob: together at University of Rochester
About
Bob Smith joined OrbiMed in 2024 as a Venture Partner, bringing over thirty years of experience across alliance management, business development, commercial, M&A, and R&D roles. He retired from Pfizer in January 2024, where he led the company's global gene therapy business, its R&D business development activities, and strategic transactions team; he originally joined Pfizer in 2009 through its acquisition of Wyeth, where he led the global M&A group. He holds a B.S. in Neuroscience and an M.B.A. in Finance and Corporate Accounting from the University of Rochester.
Invests in
Biotech
Experience
- Alliance for Regenerative MedicineChair of the Board of Directorscurrent2025 — present
- OrbiMedVenture Partnercurrent2024 — present
- Pfizer Inc.Senior Vice President, Global Gene Therapy Business2016 — 2024Collegeville, PA
- PfizerSenior Vice President, Business Development and Alliance Management2009 — 2016
- WyethSenior Vice President, Mergers and Acquisitions2008 — 2009Collegeville, PA
- Wyeth PharmaceuticalsSenior Vice President, Global Business Development2006 — 2008Collegeville, PA
Colleagues at OrbiMed
Aldo Brambilla
Associate at Silver Lake Partners
Alexander M. Cooper
Investor at OrbiMed
Anat Naschitz
Executive Officer at OrbiMed
Anat Nursella
Venture Partner at OrbiMed
Andrew P. Kanarek, CFA, CIPM
Investor at OrbiMed
Ankesh Bhansali
Investor at OrbiMed
Arun Sadhanandham
Investor at OrbiMed
Ava Poole
Investor at Insight Partners
Frequently asked questions
- Who is Bob Smith?
- Bob Smith joined OrbiMed in 2024 as a Venture Partner, bringing over thirty years of experience across alliance management, business development, commercial, M&A, and R&D roles. He retired from Pfizer in January 2024, where he led the company's global gene therapy business, its R&D business development activities, and strategic transactions team; he originally joined Pfizer in 2009 through its acquisition of Wyeth, where he led the global M&A group. He holds a B.S. in Neuroscience and an M.B.A. in Finance and Corporate Accounting from the University of Rochester.
- Where does Bob Smith work?
- Bob Smith is Venture Partner at OrbiMed.
- What does Bob Smith invest in?
- Bob Smith invests in Biotech.
- Where did Bob Smith go to school?
- Bob Smith studied at University of Rochester (Bachelor's of Science, Neuroscience); University of Rochester - Simon Business School (Master of Business Administration (MBA), Finance and Corporate Accounting).
Same school
Also attended University of Rochester157
Michael OdaiCOO & General Counsel at Mosaic VenturesCamila VieiraPartner, Head of Brazil at QED InvestorsBryan CiambellaGeneral Partner at PROOFWilliam SheahanSenior Vice President and Chief Innovation Officer at Flare Capital PartnersArtur BergmanFounder, Fastly at Amplify PartnersNicole VitulloInvestor at Arboretum Ventures
+ 151 more
Also attended University of Rochester - Simon Business School64
Camila VieiraPartner, Head of Brazil at QED InvestorsAndy WeymannVenture Partner, Frontiers in Health & Bio Investments at Verve VenturesDeepali NangiaPartner at SpeedinvestWei JiangFounder & Managing Partner at CatchLight Capital PartnersOmar FarooquiDirector of Valuation at EJF VenturesTim JonesPartner at ICI
+ 58 more
Shared employers
Also worked at Alliance for Regenerative Medicine11
Tay SalimullahVenture Partner at 4BIO CapitalMiguel ForteAdvisor at Delin VenturesMatthew R. PattersonVenture Partner - US Investments at SR One Capital ManagementAlexander VosVenture Partner at BioGeneration VenturesJason FosterVenture Partner at THENA CapitalSteven Nichtberger, MDFounder at Cabaletta Bio
+ 5 more
Also worked at Pfizer402
Jigar RaythathaInvestor at Third Rock VenturesAbbie CelnikerInvestor at Third Rock VenturesErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesRichard ChesworthInvestor at Third Rock VenturesMichael TaylorOperating Partner at Mission Biocapital
+ 396 more